tbuckley/cabot-search huggingface dataset:
The role of computers in modern medicine
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Triiodothyronine
Authors: Hossein Gharib
Journal: JAMA (1974)

Triiodothyronine (T<sub>3</sub>) is normally present in human serum, two thirds being a secretory product of thyroid gland and the remaining one third being derived from extrathyroid conversion of thyroxine to T<sub>3</sub>. Serum T<sub>3</sub>determination has become an important factor in the investigation of thyroid physiology and is now available to the clinician in the diagnosis and management of various thyroid disorders. In general, thyrotropinstimulating hormone or thyroxine levels are better diagnostic indexes of hypothyroidism, while T<sub>3</sub>determination is a useful index of thyroid hyperfunction.
Neena Modi: Dogged, determined, driven
Journal: BMJ (2016)

Dogged, determined, drivenWhat was your earliest ambition?I spent part of my childhood in India in an era when women always took second place, so my earliest ambition was to be better than the boys (and I was). Who has been your biggest inspiration?A raft of fictional heroines feature large, but I also admired Margaret Thatcher, though I detested her politics; Hillary Clinton, obviously, for her amazing resilience; similarly, Aung Sang Suu Kyi
AUTHORS' REPLY
Authors: A. J Knox, J. F. Morrison, M. F Muers
Journal: Thorax (1988)

Lung Disease amongst others.It is, however, counterproduc- tive to suggest that asthma needs to be defined with precision in some absolute sense.This is not possible either for epidemiological or for clinical studies, and is not likely to be possible until after the causes of asthma are more fully understood.What can be done is to standardise methods of diagnosis between studies and between researchers.This is an easier task.improvement could be attributed to either a learning or an copyright.
Measles—United States, First 26 Weeks, 1993
Journal: JAMA (1993)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Making Better CARs for Kids
Journal: Cancer Discovery (2018)

Researchers have found that prior chemotherapy may impair the ability to manufacture effective chimeric antigen receptor (CAR) T-cell therapies. In addition, they determined that T cells that use fatty-acid pathways for fuel had greater potential as CAR T-cell therapies than cells that relied on glycolysis. Their conclusions have led to a change in the timing of T-cell collection.
MEDICAL PROGRESS.
Journal: JAMA (1888)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Current Comment
Journal: JAMA (1925)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2024 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Dueries and Minor Notes.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal
Authors: J. Gelernter
Journal: JAMA (1993)

<h3>Objective.</h3> —An allelic association between the<i>Taq</i>I "A" system A1 allele at the D<sub>2</sub>dopamine receptor locus (DRD2) and either alcoholism or severe alcoholism has been proposed. Our purpose was to evaluate whether, based on all of the accumulated evidence, this association could be considered to be proven. <h3>Data Sources.</h3> —We considered data from all published reports of DRD2 allele frequency in alcoholics, controls, or both. <h3>Study Selection.</h3> —We concentrated on the issue of replication. We therefore considered all data reported (on white samples, because DRD2 allele frequency varies by race and ethnicity) since the first report by Blum et al in 1990. <h3>Data Synthesis.</h3> —We analyzed the set of data for differences in allele frequencies between alcoholics and controls, and for heterogeneity among samples. We also investigated the influence of the data from the first group to report an association (including a subsequent report from that group) on the findings. Our analysis shows that, when all studies subsequent to the original study are considered, there is no significant difference in DRD2 A1 allele frequency between alcoholics and controls, there is significant heterogeneity among reported alcoholics and reported controls, and there is no significant difference in DRD2 A1 allele frequency between severe and not severe alcoholics. Also, the two reports of Blum et al account for all of the (nonsignificant) differences seen between controls, alcoholics, and severe alcoholics. <h3>Conclusions.</h3> —In general, heterogeneity among studies (for alcoholics or controls) is considerably greater than differences between alcoholics and controls overall. The findings to date can best be explained by more conservative interpretations than a confirmed physiologically important allelic association between DRD2 alleles and alcoholism. These other possibilities include sampling error and ethnic variation in those studies that individually showed a large effect. (<i>JAMA</i>. 1993;269:1673-1677)
Highlights
Journal: JAMA Surgery (2018)

Patient-Reported Outcomes in Breast Reconstruction 891Despite considerable literature on breast reconstruction outcomes, studies have lacked rigorous patient-reported outcome data.Santosa and colleagues analyzed self-reported outcomes of 2013 women who had immediate breast reconstruction, comparing outcomes of those who chose autologous breast reconstruction vs those who had implant-based reconstruction.Patients with autologous reconstructions reported greater satisfaction and breastassociated quality of life at 2 years than those who had used implant-based techniques.
NEW HAMPSHIRE MEDICAL ASSOCIATIONOne Hundred and Nineteenth Annual Session, held at Concord, May 12, 1910
Journal: JAMA (1910)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Proposals for US National Health Insurance
Authors: I. Jevaji
Journal: JAMA (2003)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Usher Bats Out of the Belfry to Reduce the Risk of Rabies
Journal: JAMA (2013)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Error in Author Byline
Journal: JAMA Surgery (2020)

Jonah J. Stulberg, MD, PhD, MPH; Reiping Huang, PhD; Lindsey Kreutzer, MPH; Kristen Ban, MD; Bradley J. Champagne, MD; Scott R. Steele, MD; Julie K. Johnson, PhD; Jane L. Holl, MD, MPH; Caprice C. Greenberg, MD, MPH; Karl Y. Bilimoria, MD, MS
Birth defects. Their significance as a public health problem
Authors: V. Apgar
Journal: JAMA (1968)

Abnormal conditions of congenital origin are a leading cause of death and disability in the United States. An estimated 500,000 fetal deaths and at least 62,000 deaths among the live-born are associated with birth defects each year. An estimated 15 million persons have one or more congenital defects which affect their daily lives. Birth defects constitute a leading cause of hospitalization of children.
Correction: Interaction of Developmental Transcription Factor HOXC11 with Steroid Receptor Coactivator SRC-1 Mediates Resistance to Endocrine Therapy in Breast Cancer: Figure 3B.
Journal: Cancer Research (2010)

In this article (Cancer Res 2010;70:1585–94), which was published in the February 15, 2010 issue of Cancer Research (1), the title is incorrect; the correct title is “Interaction of Developmental Transcription Factor HOXC11 with Steroid Receptor Coactivator SRC-1 Mediates Resistance to Endocrine Therapy in Breast Cancer.” Also, there is an error in Fig. 3B; the corrected figure appears below. The online article has been changed to reflect these corrections and no longer matches the print.
Efficacité d'une endoprothèse biliaire métallique imprégnée (paclitaxel – caprate de sodium) dans la prise en charge d'obstruction biliaire maligne: une étude comparative prospective randomisée
Journal: Endoscopy (2019)

L’utilisation de prothèse imprégnée d'agents antimitotiques est évaluée depuis plusieurs années dans l’idée de rallonger la durée de perméabilité en retardant l’infiltration tissulaire intraprothétique. Cette étude évalue une endoprothèse imprégnée de troisième génération – MSCPM-III – avec une surface luminale lisse pour prévenir l'occlusion par les aliments ou le sludge, ainsi que du caprate de sodium pour améliorer la délivrance du paclitaxel. L'endoprothèse MSCPM-III comporte une couche de maille métallique entre deux membranes (membrane intérieure, PTFE; membrane extérieure, PTFE et polyuréthane), ce qui donne une surface luminale lisse, et des flaps des deux côtés pour empêcher la migration de l’endoprothèse. L'endoprothèse MSCPM-III est recouverte de 400 mg (10 %) de polymère de paclitaxel-sodium-caprate-polyuréthane et de 10 mL de solution de tétrahydrofuranne. Le but de cette étude était d'évaluer l'efficacité et l'innocuité de cette nouvelle endoprothèse chez les patients atteints d'obstruction biliaire maligne par rapport à des stents non imprégnés, étude prospective, randomisée.
846. Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7.1 in an Immuneocompetenet Mouse Model
Authors: Ji Young Yoo, Young-Sook Lee, Jaesung Kim, Hyejin Choi, Joo-Hang Kim, Chae-Ok Yun
Journal: Molecular Therapy (2006)

Interleukin (IL)-12 is reported to exhibit potent anti-tumor effect by promoting NK cell and cytotoxic T cell activities. The B7 family has been shown to take an important role in stimulating anti-tumor response, and synergy between IL-12 and B7-1 for cancer immunotherapy has previously been demonstrated. To increase the potential antitumor activity of the oncolytic adenovirus, we have constructed an E1B 55kDa deleted oncolytic adenoviral vector, YKL-IL12/B, which expresses murine IL-12 and B7.1.
Amer J Obstetrics &amp; Gynecology, St. Louis
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Authors: Miranda L. Broz, Mikhail Binnewies, Bijan Boldajipour, Amanda E. Nelson, Joshua L. Pollack, David J. Erle, Andrea Barczak, Michael D. Rosenblum, Adil Daud, Diane L. Barber, Sebastian Amigorena, Laura J. van’t Veer, Anne I. Sperling, Denise M. Wolf, Matthew F. Krummel
Journal: Cancer Cell (2014)
Computerized IV arteriography offers diagnostic alternative
Authors: W. A. Check
Journal: JAMA (1980)

In what one prominent surgeon described as a "landmark presentation," investigators from the University of Wisconsin Clinical Science Center, Madison, have reported impressive success with a form of arteriography that may obviate much of the need for arterial catheterization in studying the peripheral vasculature. The method, called computerized intravenous arteriography, clearly visualized the intracranial and extracranial arterial tree, the aortic arch, the abdominal artery and its branches, and vessels of both upper and lower extremities, according to William D. Turnipseed, MD, and Andrew B. Crummy, MD. Turnipseed, an associate professor of surgery, and Crummy, a professor of radiology, described the approach to members of the Society for Vascular Surgery in Chicago (Figures). Their presentation earned the "landmark" praise from John Mannick, MD, chief of surgery, Brigham and Women's Hospital, and professor of surgery, Harvard Medical School, Boston. Turnipseed and Crummy stressed that this procedure is more than a research tool.
Demyelinating Diseases
Authors: George A. Schumacher
Journal: New England Journal of Medicine (1960)

Multiple SclerosisEpidemiologyThe aim of numerous epidemiologic investigations has been to uncover possible etiologic factors. A summary of the earlier surveys carried out in Europe and those in this country before 1954 is contained in the work by McAlpine, Compston and Lumsden.8 Multiple sclerosis has a world-wide distribution, but its incidence appears to be quite uneven. Statistical investigations have increased during the past decade, though reliable surveys for areas below the equator are sparse. In the northern hemisphere, on the American continent, the disease occurs more frequently in the northern latitudes,135 , 136 the incidence and prevalence rates being three times . . .
The modern monitor-defibrillator. A potential source of falsely abnormal ECG recordings
Authors: R. A. Stein
Journal: JAMA (1981)

Portable monitor-defibrillators with ECG strip chart records are in standard hospital use. When supplied with five-lead systems, these units can generate full 12-lead ECGs. Most of the units evaluated by us were designed with nondiagnostic frequency-response characteristics, which can lead to the generation of a 12-lead ECG with false ST depression. The recordings may not be identified as of nondiagnostic quality and thus adversely affect the patient's management. (<i>JAMA</i>1981;246:1697-1698)
Reversion of chronic atrial fibrillation
Authors: A. A. Futral
Journal: JAMA (1967)

The value of reversion of chronic, established atrial fibrillation has been assessed by reviewing the status of 50 patients after at least 3 months and after an average of 11 months following attempted reversion. Only 19 of these patients maintained normal rhythm, a proportion which is similar to most previously reported experiences by others. At least one instance of ventricular fibrillation due to quinidine sulfate occurred. Within this relatively small group, normal rhythm was successfully maintained almost exclusively in patients with hemodynamically minor heart disease or in those who had undergone ameliorative cardiac surgery. Although the simplicity and immediate efficacy of the reversion procedure was again demonstrated, its value in patients whose chronic atrial fibrillation was associated with stable or progressive congestive heart failure appeared to be limited.